NeutriSci International Inc V.NU.H

Alternate Symbol(s): NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.

TSXV:NU.H - Post by User

NeutriSci International Inc > Latest Financials

<< Previous

Bullboard Posts

Next >>

Comment by CaptainCrunchyon May 29, 2021 5:46pm

48 Views

Post# 33293164

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Latest Financials

which, we expect some very relevant news in a short time frame. (Vague as always) The next quarterly will show the order revenue, the deferred for second order. When shipped, the deferred revenue will be plucked out of asset of inventory on balance sheet. This shouldn't matter, cause, we should have deferred revenue for the second order and replenished inventory to replace the asset. We should be able to decipher quite alot even if they don't tell us, just wish they would tell us. Waiting until next finacials and weeding out details is no way to inspire confidence.

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3